What is the recommended DVT prophylaxis and compression stocking regimen for a patient after hip fracture surgery?

Post Hip Fracture DVT Prophylaxis and Compression Stockings

For patients after hip fracture surgery, pharmacological DVT prophylaxis with LMWH (enoxaparin 30 mg twice daily or 40 mg once daily) should be initiated 12-24 hours postoperatively and continued for a minimum of 10-14 days, with strong consideration for extended prophylaxis up to 35 days, combined with mechanical prophylaxis using intermittent pneumatic compression (IPC) devices intraoperatively and during hospitalization. 1, 2, 3

Pharmacological Prophylaxis Regimen

The evidence strongly supports LMWH as the primary agent for hip fracture patients:

• Enoxaparin dosing: 30 mg subcutaneous twice daily starting 12 hours before or after surgery, OR 40 mg once daily 1
• Duration: Minimum 10-14 days, with extended prophylaxis up to 35 days for high-risk patients 1, 4, 5
• Timing: Should be initiated as soon as possible after injury, ideally within 12 hours of admission 6, 7

Alternative agents include:

• Dalteparin: 5000 IU once daily 1
• Fondaparinux: 2.5 mg once daily (1.5 mg if CrCl 30-50 mL/min) 1
• Rivaroxaban: 10 mg once daily starting 6-10 hours postoperatively 1

Important caveat: Recent high-quality evidence from 2026 shows rivaroxaban carries significantly higher bleeding risk (22.64%) compared to LMWH (5.17%) or aspirin (4.00%), with comparable DVT prevention efficacy 8. This suggests LMWH remains the safer choice despite rivaroxaban's oral convenience.

Mechanical Prophylaxis and Compression Stockings

Graduated compression stockings and/or IPC devices should be used as adjunctive therapy, not as sole prophylaxis 1, 6:

• IPC devices: Recommended intraoperatively and during hospitalization 6, 2
• Graduated compression stockings: Can be used but have compliance issues 9, 10
• Foot pumps: Effective alternative to calf compression 11, 12

Mechanical methods alone are only appropriate when pharmacological prophylaxis is contraindicated due to high bleeding risk 1, 9.

Clinical Algorithm for Implementation

1. At admission (within 12 hours of injury):

   • Assess bleeding risk and contraindications
   • Apply IPC devices or graduated compression stockings
   • If no contraindications, start LMWH prophylaxis 7

2. Perioperatively:

   • Continue mechanical prophylaxis intraoperatively 6
   • Hold LMWH dose on morning of surgery if given twice daily
   • Resume LMWH 12-24 hours postoperatively once hemostasis assured 1

3. Postoperative period:

   • Continue LMWH for minimum 10-14 days 1
   • Maintain mechanical prophylaxis during hospitalization
   • Consider extended prophylaxis (up to 35 days) for patients with:
     • Limited mobility
     • Multiple comorbidities (≥2) 13
     • Delayed surgery (>48 hours from injury) 13
     • History of coronary disease 14
     • Elevated D-dimer (≥5.26 mg/L) 14

4. At discharge:

   • Prescribe extended LMWH prophylaxis (total 4 weeks recommended) 2
   • Provide clear instructions for self-injection or arrange home health
   • Discontinue compression stockings at discharge (IPC not practical at home)

Special Considerations and Pitfalls

Timing is critical: The risk of DVT increases with time from injury to surgery 6, 7, 13. Surgery should be performed as soon as medically feasible, and prophylaxis should begin immediately upon admission, not just postoperatively.

Bleeding risk management:

• For patients at high bleeding risk, use mechanical prophylaxis alone initially 1
• Once bleeding risk diminishes (typically 48 hours post-op), add pharmacological prophylaxis 1
• Avoid rivaroxaban in elderly patients due to significantly higher bleeding rates 8

Renal dosing: Adjust enoxaparin to 30 mg once daily if CrCl <30 mL/min 9; fondaparinux to 1.5 mg if CrCl 30-50 mL/min 1

Aspirin is insufficient: While aspirin reduces VTE risk, it does not provide optimal protection compared to LMWH and should not be used as sole prophylaxis 10, 11

Compression stocking compliance: Graduated compression stockings have documented compliance problems and skin complications 10, 11. IPC devices are more reliable during hospitalization but impractical post-discharge.

Extended prophylaxis matters: The VTE risk persists for up to 2 months post-surgery 4. The 2022 AAOS guidelines upgraded their recommendation strength for VTE prophylaxis to "strong" based on accumulating evidence of benefit 2, 3.

The evidence consistently demonstrates that hip fracture patients have exceptionally high VTE risk (37% DVT, 6% PE without prophylaxis) 6, with 24% developing DVT even with standard prophylaxis 13. This justifies aggressive combined mechanical and pharmacological prophylaxis with extended duration.